Interim Data Shows Real-World Insights into Ranibizumab Treatment Practices
The PACIFIC study is currently evaluating health care management practice with intravitreal ranibizumab 0.5 mg for various ophthalmologic diseases.
Study Explores Associations Between DME and Proliferative Diabetic Retinopathy
An ARVO 2021 study characterizes patients with diabetic retinopathy who have also developed diabetic macular edema.
Study Identifies Potential Type 2 Diabetes plus Dry Eye Biomarkers
New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.
Expanding Sepofarsen Understanding in LCA10
After promising early findings for the investigative therapy in a rare form of blindness, investigators turn to the next phase.
Glycemic Control Not Always Enough to Prevent Vision Loss in Diabetics
New research from ARVO 2020 suggests patients with diabetic eye disease can still experiences losses in visual acuity, even with glycemic control.
Impact of Hereditary Retinitis Pigmentosa on Activity, Quality of Life
A survey of 19 patients with hereditary retinitis pigmentosa details the impact of the disease on the quality of life and daily activity of patients and caregivers.
Patient Anxiety Linked to Pain from Anti-VEGF Injections
Gauging patient wellbeing prior to intravitreal injections may help inform clinicians as to who may fare worse with the treatment.
Sepofarsen Benefits Genetic Form of Blindness in Early Trials
A breakdown of a new 12-month, phase 1b/2 assessment of the RNA therapy in patients with LCA10.
Few RVO Patients Prescribed Anti-VEGF after Macular Edema Diagnosis
A new assessment shows about 60% of treatment-naive patients are not prescribed the most common drug class within 1 year of secondary edema.
Visual Impairment, Dementia Are Detrimental to Independence of Older Adults
New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.
New AI Model Could Aid in Diagnosis of Age-Related Macular Degeneration
A new AI model from the New York Eye and Ear Infirmary of Mount Sinai boasts 99.2% accuracy for diagnosing intermediate or late AMD.
Vitamin D and Homotaurine Show Potential Benefit for Macular Degeneration
Discussing the results of a study examining impact of vitamin D and homotaurine supplementation on early to intermediate age-related macular degeneration.
Fluoroquinolone Effective Initial Treatment for MRSA Keratitis
Fortified vancomycin causes antibiotic resistance and corneal toxicity.
Brolucizumab Linked to Decreases in nAMD Disease Activity Versus Aflibercept
Rishi Singh, MD, discusses differences in disease activity noted among nAMD patients enrolled in the pivotal HAWK and HARRIER trials.
Sumit Sharma, MD: Learning About NIU-PS Disease Course from Fellow Eyes
Discussing what data from fellow eyes of a 3-year study tell us about disease course of non-infectious uveitis of the posterior segment with an assistant professor from the Cole Eye Institute.
Superior Placement Risk Factor For Premature Monocanalicular Stent Extrusion
Male sex and younger age are also risk factors for premature stent extrusion.
Pooled Analysis Highlights Safety, Efficacy of Satralizumab for NMOSD
A Q&A with the medical director of clinical ophthalmology with Genentech about the humanized monoclonal antibody in treatment of NMOSD.
High-Intensity Statins May Not Prevent Dry to Wet AMD Progression
Discussing the impact of high-intensity statin therapy on patients with dry AMD with a study investigator from Byers Eye Institute.
Dexamethasone Intracameral Drug-Delivery Suspension for Post-Op Inflammation
Daniel Kiernan, MD, discusses the results of a study examining dexamethasone intracameral drug-delivery suspension compared with topical corticosteroids for inflammation following vitreoretinal surgery.
Optogenetic Gene Therapy Well Tolerated For Retinitis Pigmentosa
Investigators are evaluating the safety and tolerability of an optogenetic treatment combining a gene therapy and a medical device.
Arshad Khanani, MD: ADVM-022 Insights from OPTIC Trial Cohorts 1-3
Discussing the latest data from Adverum Biotechnologies related to ADVM-022 and the ongoing phase 1 OPTIC trial with the trial's principal investigator.
Educational Cartoon Improves Ambylopia Treatment Compliance in Children
Research from ARVO 2020 suggest a 4-minute educational video could more than double compliance with patching in pediatric patients with ambylopia.
Franco Recchia, MD: PDS with Ranibizumab, LADDER End of Study Results
Discussing how end of study results from the phase 2 LADDER trial inform clinicians on the use of PDS with ranibizumab.
Different Treatment Approach Needed for NAMD
An analysis suggests different regimens evaluated for nAMD did not result in superior vision benefits compared with ranibizumab pro re nata or four-week dosing.
VR Headsets Clinically Useful for Visual Field Testing
Virtual reality devices are proving to be practical and convenient way of screening for and monitoring glaucoma.
Diabetic Retinopathy Patients More Likely to Experience Depression, Anxiety
New research suggests the prevalence of depression and anxiety is greater among patients with diabetic retinopathy.
STAIRWAY Analysis Details Clinical Effects of Faricimab Use for nAMD
A new analysis of STAIRWAY from ARVO 2020 is shedding additional light on the effects of faricimab use.
Brian Toy, MD: Risk Factors for Uveitis
Investigators found that female sex, older age, and certain comorbidities were associated with an increased risk of uveitis.
Brian Toy, MD: Incidence of Uveitis in the US
Using a national medical claims database, investigators found the incidence and prevalence of uveitis in the US.
Real-World Outcomes of FAc Implant
Results from the 3-year European Iluvien Registry Safety Study that examined outcomes of the fluocinolone acetonide implant compared to those of the pivotal FAME trials.
